Meta-Analysis Links Omega-3 Fatty Acid Consumption to T2DM
Composition, ethnicity, trial duration, recruited age all influence effect of omega-3 on T2DM progression
2000 to 2011 Saw Shift in Treatment for Advanced NSCLC
Rise in use of pemetrexed, erlotinib, bevacizumab; longest treatment duration with these agents
Letrozole Tops Aspirin for Halting Ovarian Hyperstimulation
Decreases incidence of moderate and severe early-onset ovarian hyperstimulation syndrome
Sequential Empagliflozin, Linagliptin Diabetes Tx Effective
Glucose control most probably mediated by effects on alpha- and beta-cell function
Fenofibrate May Reduce CVD in Patients With DM, Dyslipidemia
No reduction in primary outcome for 4,644 ACCORD participants followed for median of 9.7 years
Non-Liver-Related Critical Events Down With SVR in HCV+Cirrhosis
Study confirms reduction in critical events, liver-related or not
Metformin Tied to Better Clinical Outcomes in CKD, CHF, CLD
Reduced all-cause death for chronic kidney disease, congestive heart failure, chronic liver disease
Too Few U.S. Young Adults Being Prescribed Needed Statins
Guidelines suggest medications could help prevent CVD, but many younger people missing out
More Cognitive Difficulties for Patients After Chemotherapy
Breast cancer survivors report cognitive issues after chemo, through six-month follow-up
Retailers Often Recommend Age-Restricted Supplements to Teens
Authors say pediatricians need to discourage their use for athletic performance
